Just like the non-celeb normies of the world, Gage has toxic traits, experience with STIs, and conflicting views on hookup ...

In an exclusive interview with The Blast, Lukas Gage speaks about the importance of prioritizing health and well-being.

Lenacapavir, developed by Gilead Sciences and approved earlier this year for HIV prevention under the brand name Yeztugo, is ...

The 39th annual event aims to raise $500,000 to support Whitman-Walker’s HIV testing, outreach, prevention, and treatment ...

Ibrahim Lwingi lost many family members to HIV/AIDS and says he likely would've been next without prevention meds from ...

OKLAHOMA CITY, Sept. 11, 2025 /PRNewswire/ -- Equality Health is increasing its efforts to prevent HIV by increasing the availability of PrEP (pre-exposure prophylaxis) throughout Oklahoma. This ...

An X-ray crystal structure of MK-8527 triphosphate (TP) bound to the complex of HIV reverse transcriptase and DNA shows the drug candidate’s alkyne extending into a key pocket to the upper left of the ...

Charlie Sheen wasn't expecting to endure a "sixth" stage of grief after receiving his HIV-positive diagnosis in 2011. In his new memoir, "The Book of Sheen," the award-winning actor admitted that ...

The U.S. announced Thursday that it will make an investment in the new HIV prevention drug called lenacapavir that's been hailed as a "breakthrough" and a "game changer" by the medical community. The ...

The U.S. is purchasing enough doses of a new twice-a-year HIV prevention shot to share with up to 2 million people in poor countries by 2028 ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced a partnership with the U.S. State Department and the United States President’s Emergency Plan for AIDS Relief ...

WASHINGTON (AP) — The U.S. is purchasing enough doses of a new twice-a-year HIV prevention shot to share with up to 2 million people in poor countries by 2028, the State Department announced Thursday.